Loading data
PRSONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 14.57 m USD | 13.75 m USD | 14.87 m USD | 5.68 m USD |
| Cost of revenue | 5.13 m USD | 7.04 m USD | 11.88 m USD | 8.92 m USD | 3.27 m USD |
| Gross profit | 7.07 m USD | 7.53 m USD | 1.87 m USD | 5.95 m USD | 2.41 m USD |
| Research and development expense | 6.25 m USD | 9.23 m USD | 14.4 m USD | 19.77 m USD | 11.47 m USD |
| Selling, general and administrative expense | 5.81 m USD | 8.67 m USD | 8.51 m USD | 11.11 m USD | 7.02 m USD |
| Operating profit | -4.76 m USD | -12.44 m USD | -20.63 m USD | -32.31 m USD | -16.08 m USD |
| Interest expense | — | — | 21 k USD | 16 k USD | 2.98 m USD |
| Net income (reported basis) | -4.75 m USD | -10.73 m USD | -16.8 m USD | -32.4 m USD | -10.91 m USD |
| Basic earnings per share | -0.67 USD/share | -3.57 USD/share | -26 USD/share | -64.41 USD/share | -1.86 USD/share |
| Diluted earnings per share | -0.67 USD/share | -3.57 USD/share | -26 USD/share | -64.41 USD/share | -1.86 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.